ORBIMED ADVISORS LLC

Holdings History for Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Symbol: VTGN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 1,639,700 shares
Security Ownership %: 4.2%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED CAPITAL LLC ownership in Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)

17 Feb 2026 - ORBIMED CAPITAL LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,639,700 shares of Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN). This represents 4.2% ownership of the company. In their previous filing dated 14 Nov 2025, ORBIMED ADVISORS LLC had reported owning 1,639,700 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED CAPITAL LLC	4.2%	-23%	$1,213,378	1,639,700	0		$0.74	13G/A	31 Dec 2025	17 Feb 2026, 18:33
ORBIMED CAPITAL LLC	5.3%		$5,820,935	1,639,700			$3.55	13G	30 Sep 2025	14 Nov 2025, 18:04

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.04%	0%	$2,025,414	3,060,000	0		$0.66	Q4 2025
31 Dec 2025	call	0.23%	0%	$29,918	45,200	0		$0.66	Q4 2025
30 Sep 2025		0.26%	+0.26%	$10,863,000	3,060,000	+3,060,000	NEW	$3.55	Q3 2025
30 Sep 2025	call	0.19%	+0.19%	$160,460	45,200	+45,200	NEW	$3.55	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.